Nafamostate Mesylate is a significant part of Loncom Pharma's offerings, providing solutions for specific healthcare needs and improving patient well-being.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
